Apolipoprotein B RNA editing enzyme-deficient mice are viable despite alterations in lipoprotein metabolism.

Por Morrison, J R, Pászty, C, Stevens, M E, Hughes, S D, Forte, T, Scott, J, Rubin, E M
Publicado em 1996

Targeted disruption of the mouse beta1-adrenergic receptor gene: developmental and cardiovascular effects.

Por Rohrer, D K, Desai, K H, Jasper, J R, Stevens, M E, Regula, D P, Barsh, G S, Bernstein, D, Kobilka, B K
Publicado em 1996

Cost benefits of low dose subcutaneous erythropoietin in patients with anaemia of end stage renal disease.

Por Stevens, M. E., Summerfield, G. P., Hall, A. A., Beck, C. A., Harding, A. J., Cove-Smith, J. R., Paterson, A. D.
Publicado em 1992